Pure Global
NCT05389995

Potassium Citrate and Crystal Light Lemonade

Assessing the Effects of a Commercial Lemonade Beverage and Potassium Citrate on Urinary Stone Risk Factors
Northwestern University·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Kidney Stone
Drug/Device/Intervention
Potassium citrate
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Northwestern University
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2022
End date
Dec 31, 2023
Enrollment
10 participants
Primary outcome

urine citrate levels,urine citrate levels,urine citrate levels

Summary

To define the effect of crystal light, potassium citrate, or both on urinary stone risk
 factors in patients with a history of stone and hypocitraturia/low pH

ICD-10 classifications
Kidney dialysisSmall kidney, unspecifiedDisorder of kidney and ureter, unspecifiedInjury of kidneyUnspecified kidney failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05389995
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05389995 through Pure Global AI's free database. This phase not specified trial is sponsored by Northwestern University and is currently Not yet recruiting. The study focuses on Kidney Stone. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.